This page lists the SEC filings reported by JPMORGAN CHASE & CO.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | RAYONIER INC | 8,612,461 | 5.8% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | REGENERON PHARMACEUTICALS, INC. | 7,219,436 | 6.7% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | REGENXBIO Inc. | 3,932,521 | 8.9% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Revance Therapeutics, Inc. | 4,754,771 | 5.4% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Seagate Technology Holdings plc | 17,954,208 | 8.5% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | StepStone Group Inc. | 3,412,981 | 5.3% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Summit Hotel Properties, Inc. | 6,656,890 | 5.8% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Trane Technologies plc | 17,198,303 | 7.5% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Twist Bioscience Corp | 4,462,494 | 7.7% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Utz Brands, Inc. | 5,108,617 | 6.2% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | EXACT SCIENCES CORP | 17,342,002 | 9.5% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | Hillman Solutions Corp. | 10,459,346 | 5.3% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | IAC Inc. | 5,605,129 | 7.0% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | Information Services Group Inc. | 2,619,838 | 5.3% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | LOEWS CORP | 13,195,141 | 5.9% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | Natera, Inc. | 7,964,473 | 6.6% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | NLIGHT, INC. | 3,518,955 | 7.5% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | NXP Semiconductors N.V. | 26,200,067 | 10.1% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | Outset Medical, Inc. | 4,745,757 | 9.4% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | PMV Pharmaceuticals, Inc. | 3,674,814 | 7.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.